Replies to post #99703 on Amarin Corp Plc (AMRN)

[Benny7459]

Do you not remember ICPT a few years back. This stock received trial results and hit 8B MC. This company is still sitting at 2.8B MC and is generating about 20M a year in revenue. This is Biotech!!

[sts66]

AMRN easily tops $5 on positive R-IT news, it's nuts to think it would only go 40% above current price for a drug with such a huge potential market. Look at what happened to ICPT in 2014 when they announced positive P2 results for their NASH drug - pps shot from $70 to an intraday high of $497 (closed at $450) in 3 days. Big difference is they only have 25M shrs out, NASH is a HUGE unmet need, and I can almost guarantee you a large part of that pop was due to a short squeeze - pps dropped back $250 2 days later, probably because shorts piled back on at the top after being forced to cover - the 3 day rise in pps points to margin calls/short covers. That's one reason to consider taking some profits on big R-IT news if we see a short squeeze, although current short ratio is a mere 3.65 (have no idea what ICPTs was back then).